 Daniel Frank
Concepts (780)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 726 | 6.010 |
Why?
| | Gastrointestinal Microbiome | 46 | 2025 | 638 | 5.490 |
Why?
| | Sinusitis | 17 | 2023 | 205 | 5.010 |
Why?
| | Rhinitis | 15 | 2022 | 152 | 4.980 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 523 | 3.320 |
Why?
| | Bacteria | 34 | 2023 | 815 | 3.320 |
Why?
| | Metagenome | 15 | 2019 | 137 | 3.220 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 74 | 2.450 |
Why?
| | Intestines | 15 | 2022 | 347 | 2.280 |
Why?
| | Dysbiosis | 18 | 2025 | 168 | 2.230 |
Why?
| | Otitis Media | 8 | 2025 | 163 | 2.190 |
Why?
| | Feces | 24 | 2025 | 432 | 2.000 |
Why?
| | RNA, Bacterial | 12 | 2018 | 182 | 1.630 |
Why?
| | Intestinal Mucosa | 19 | 2020 | 575 | 1.620 |
Why?
| | Nasal Polyps | 5 | 2021 | 58 | 1.510 |
Why?
| | Nose | 4 | 2018 | 66 | 1.460 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 431 | 1.390 |
Why?
| | Nasal Cavity | 6 | 2023 | 53 | 1.340 |
Why?
| | Ileum | 5 | 2020 | 116 | 1.260 |
Why?
| | Bacteremia | 6 | 2018 | 192 | 1.240 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 780 | 1.240 |
Why?
| | Crohn Disease | 6 | 2020 | 211 | 1.190 |
Why?
| | Phylogeny | 25 | 2020 | 847 | 1.180 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 183 | 1.110 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 389 | 1.070 |
Why?
| | Chronic Disease | 17 | 2022 | 1727 | 1.020 |
Why?
| | HIV Infections | 15 | 2025 | 2721 | 0.970 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 33 | 0.920 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 41 | 0.900 |
Why?
| | Clostridium Infections | 4 | 2018 | 58 | 0.870 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 40 | 0.860 |
Why?
| | Nasopharynx | 5 | 2024 | 67 | 0.820 |
Why?
| | Endoribonucleases | 8 | 2002 | 70 | 0.820 |
Why?
| | Humans | 134 | 2025 | 130305 | 0.820 |
Why?
| | Biodiversity | 13 | 2020 | 371 | 0.820 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.790 |
Why?
| | Bacterial Infections | 3 | 2015 | 236 | 0.790 |
Why?
| | Cholesteatoma | 1 | 2022 | 11 | 0.780 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 312 | 0.780 |
Why?
| | Inflammation Mediators | 3 | 2023 | 509 | 0.750 |
Why?
| | Breast Feeding | 6 | 2023 | 427 | 0.750 |
Why?
| | RNA, Catalytic | 7 | 2001 | 185 | 0.750 |
Why?
| | Database Management Systems | 2 | 2013 | 48 | 0.730 |
Why?
| | Drinking Water | 1 | 2022 | 76 | 0.710 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.700 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.700 |
Why?
| | User-Computer Interface | 2 | 2013 | 148 | 0.690 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 104 | 0.680 |
Why?
| | Inflammation | 12 | 2023 | 2721 | 0.680 |
Why?
| | Male | 67 | 2025 | 63748 | 0.680 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2854 | 0.670 |
Why?
| | Software | 3 | 2021 | 616 | 0.660 |
Why?
| | Colon | 8 | 2023 | 253 | 0.660 |
Why?
| | Female | 76 | 2025 | 68842 | 0.660 |
Why?
| | Burns | 4 | 2025 | 289 | 0.650 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1051 | 0.640 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 139 | 0.640 |
Why?
| | Esomeprazole | 1 | 2018 | 6 | 0.630 |
Why?
| | Infant Food | 2 | 2025 | 67 | 0.630 |
Why?
| | Infant Nutritional Physiological Phenomena | 3 | 2025 | 144 | 0.620 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 114 | 0.610 |
Why?
| | HIV-1 | 8 | 2024 | 843 | 0.600 |
Why?
| | Animals | 54 | 2025 | 35076 | 0.600 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 433 | 0.600 |
Why?
| | Iron | 3 | 2017 | 287 | 0.590 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 162 | 0.590 |
Why?
| | Adult | 44 | 2025 | 35711 | 0.580 |
Why?
| | Genes, rRNA | 3 | 2015 | 41 | 0.570 |
Why?
| | Fatty Liver | 2 | 2021 | 232 | 0.560 |
Why?
| | Vagina | 5 | 2016 | 175 | 0.540 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 533 | 0.540 |
Why?
| | Middle Aged | 37 | 2025 | 31322 | 0.530 |
Why?
| | Membrane Proteins | 3 | 2021 | 1121 | 0.530 |
Why?
| | Pharynx | 1 | 2016 | 56 | 0.520 |
Why?
| | Nose Diseases | 1 | 2016 | 12 | 0.510 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 15 | 0.510 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 259 | 0.510 |
Why?
| | Diet | 8 | 2025 | 1214 | 0.510 |
Why?
| | Case-Control Studies | 15 | 2020 | 3369 | 0.510 |
Why?
| | Mice | 28 | 2025 | 16832 | 0.500 |
Why?
| | Biofilms | 5 | 2016 | 248 | 0.490 |
Why?
| | Base Sequence | 18 | 2015 | 2162 | 0.490 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 135 | 0.490 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 62 | 0.480 |
Why?
| | Immunity, Innate | 4 | 2019 | 814 | 0.470 |
Why?
| | Food | 2 | 2020 | 170 | 0.470 |
Why?
| | Endotoxemia | 2 | 2014 | 96 | 0.460 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5083 | 0.460 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 131 | 0.450 |
Why?
| | Hippocampus | 1 | 2018 | 797 | 0.440 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 45 | 0.440 |
Why?
| | Genome, Bacterial | 4 | 2016 | 137 | 0.430 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 181 | 0.430 |
Why?
| | Computer Graphics | 1 | 2013 | 42 | 0.430 |
Why?
| | Lactobacillus | 4 | 2022 | 26 | 0.420 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 87 | 0.420 |
Why?
| | Lipid Metabolism | 2 | 2020 | 496 | 0.420 |
Why?
| | Iron, Dietary | 1 | 2013 | 21 | 0.410 |
Why?
| | Immunoglobulin A | 4 | 2022 | 193 | 0.410 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 349 | 0.410 |
Why?
| | Ear, Middle | 6 | 2025 | 93 | 0.400 |
Why?
| | Liver | 4 | 2020 | 1846 | 0.400 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.400 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 217 | 0.400 |
Why?
| | Smoking | 2 | 2020 | 1505 | 0.400 |
Why?
| | Genitalia, Female | 1 | 2012 | 38 | 0.390 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 201 | 0.390 |
Why?
| | Probiotics | 5 | 2018 | 53 | 0.390 |
Why?
| | Diet, High-Fat | 3 | 2019 | 240 | 0.390 |
Why?
| | Mice, Inbred C57BL | 15 | 2025 | 5365 | 0.380 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 336 | 0.370 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1712 | 0.370 |
Why?
| | Livestock | 1 | 2010 | 5 | 0.360 |
Why?
| | Genomics | 4 | 2020 | 723 | 0.360 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 166 | 0.350 |
Why?
| | Obesity | 7 | 2023 | 2869 | 0.350 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 23 | 0.350 |
Why?
| | Stress, Psychological | 1 | 2018 | 1058 | 0.350 |
Why?
| | Computational Biology | 3 | 2019 | 600 | 0.350 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 9 | 0.340 |
Why?
| | Asthma | 2 | 2015 | 2265 | 0.340 |
Why?
| | Escherichia coli | 9 | 2017 | 786 | 0.340 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.340 |
Why?
| | DNA Primers | 3 | 2009 | 523 | 0.340 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 57 | 0.340 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 20 | 0.340 |
Why?
| | Bacterial Translocation | 4 | 2019 | 39 | 0.340 |
Why?
| | Weight Loss | 3 | 2021 | 728 | 0.330 |
Why?
| | Agriculture | 1 | 2010 | 92 | 0.330 |
Why?
| | Genome | 2 | 2009 | 278 | 0.330 |
Why?
| | Arthritis, Experimental | 2 | 2023 | 128 | 0.330 |
Why?
| | Fluoroquinolones | 1 | 2009 | 45 | 0.330 |
Why?
| | Catheterization | 2 | 2009 | 178 | 0.320 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 36 | 0.320 |
Why?
| | Behavior Therapy | 2 | 2021 | 239 | 0.310 |
Why?
| | Butyrates | 2 | 2021 | 54 | 0.310 |
Why?
| | Corynebacterium | 4 | 2022 | 48 | 0.310 |
Why?
| | Wound Infection | 1 | 2009 | 32 | 0.310 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 2 | 0.310 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1115 | 0.300 |
Why?
| | Infant | 16 | 2025 | 9049 | 0.300 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 884 | 0.300 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.300 |
Why?
| | Confidentiality | 1 | 2008 | 70 | 0.300 |
Why?
| | Milk, Human | 4 | 2023 | 149 | 0.300 |
Why?
| | Seafood | 2 | 2025 | 27 | 0.290 |
Why?
| | Transcriptome | 5 | 2021 | 890 | 0.290 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 14 | 0.290 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 166 | 0.290 |
Why?
| | Pedigree | 4 | 2025 | 493 | 0.290 |
Why?
| | DNA, Bacterial | 6 | 2017 | 325 | 0.290 |
Why?
| | Video Recording | 1 | 2008 | 163 | 0.290 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 34 | 0.280 |
Why?
| | Pneumonia | 2 | 2025 | 616 | 0.280 |
Why?
| | Genes, Bacterial | 5 | 2018 | 159 | 0.280 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 307 | 0.280 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 83 | 0.280 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4044 | 0.280 |
Why?
| | RNA, Transfer | 3 | 1998 | 131 | 0.270 |
Why?
| | Congresses as Topic | 1 | 2008 | 218 | 0.270 |
Why?
| | Aged | 16 | 2023 | 22282 | 0.270 |
Why?
| | Homeostasis | 5 | 2020 | 613 | 0.270 |
Why?
| | Perilipin-2 | 2 | 2017 | 36 | 0.260 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 706 | 0.260 |
Why?
| | Carrier Proteins | 1 | 2010 | 738 | 0.260 |
Why?
| | Genotype | 4 | 2019 | 1839 | 0.260 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 58 | 0.260 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 82 | 0.260 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3629 | 0.260 |
Why?
| | Dietary Supplements | 3 | 2019 | 534 | 0.260 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1101 | 0.250 |
Why?
| | Public Health | 1 | 2010 | 496 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2282 | 0.250 |
Why?
| | Neoplasms | 2 | 2018 | 2467 | 0.250 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 87 | 0.250 |
Why?
| | Diet, Western | 3 | 2022 | 79 | 0.250 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Research | 1 | 2008 | 415 | 0.240 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 586 | 0.240 |
Why?
| | Phenotype | 8 | 2020 | 3084 | 0.240 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 158 | 0.240 |
Why?
| | Construction Materials | 2 | 2015 | 13 | 0.230 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 378 | 0.230 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 489 | 0.230 |
Why?
| | Cohort Studies | 7 | 2022 | 5431 | 0.230 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 195 | 0.230 |
Why?
| | Palatine Tonsil | 1 | 2024 | 45 | 0.230 |
Why?
| | Air Microbiology | 2 | 2015 | 41 | 0.220 |
Why?
| | Glycerophospholipids | 1 | 2024 | 32 | 0.220 |
Why?
| | Young Adult | 13 | 2024 | 12404 | 0.220 |
Why?
| | Biomarkers | 9 | 2024 | 3923 | 0.220 |
Why?
| | Infant Formula | 2 | 2023 | 76 | 0.220 |
Why?
| | Pregnancy | 11 | 2025 | 6301 | 0.220 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 154 | 0.220 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 111 | 0.220 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 29 | 0.210 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 94 | 0.210 |
Why?
| | RNA Splicing | 3 | 1995 | 262 | 0.210 |
Why?
| | RNA, Fungal | 5 | 2002 | 67 | 0.210 |
Why?
| | Colitis | 3 | 2020 | 240 | 0.210 |
Why?
| | Adolescent | 13 | 2024 | 20374 | 0.210 |
Why?
| | Ear Canal | 1 | 2003 | 16 | 0.210 |
Why?
| | Alternative Splicing | 1 | 2025 | 219 | 0.200 |
Why?
| | Sepsis | 2 | 2023 | 565 | 0.200 |
Why?
| | Species Specificity | 4 | 2020 | 571 | 0.200 |
Why?
| | Ribonuclease P | 7 | 2001 | 25 | 0.200 |
Why?
| | Gene Ontology | 1 | 2022 | 49 | 0.200 |
Why?
| | Fungal Proteins | 2 | 2000 | 129 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.200 |
Why?
| | Olfaction Disorders | 1 | 2023 | 60 | 0.200 |
Why?
| | Genetic Variation | 4 | 2018 | 939 | 0.200 |
Why?
| | Disease Susceptibility | 3 | 2020 | 340 | 0.200 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 8 | 0.200 |
Why?
| | Exome | 2 | 2020 | 220 | 0.200 |
Why?
| | Mycobacterium | 1 | 2023 | 111 | 0.190 |
Why?
| | Child, Preschool | 10 | 2025 | 10514 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 381 | 0.190 |
Why?
| | Immunity | 2 | 2014 | 137 | 0.190 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 475 | 0.190 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1056 | 0.190 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 111 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 52 | 0.190 |
Why?
| | Haemophilus Infections | 1 | 2022 | 40 | 0.190 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 209 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 174 | 0.180 |
Why?
| | Child | 12 | 2025 | 20961 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.180 |
Why?
| | Genes, Fungal | 4 | 2000 | 52 | 0.180 |
Why?
| | Nutritional Status | 2 | 2014 | 328 | 0.180 |
Why?
| | Health | 2 | 2012 | 74 | 0.180 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 242 | 0.180 |
Why?
| | Ascomycota | 1 | 2000 | 31 | 0.180 |
Why?
| | Ear, External | 1 | 2020 | 24 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 528 | 0.170 |
Why?
| | Plasminogen | 1 | 2020 | 32 | 0.170 |
Why?
| | Islets of Langerhans | 3 | 2015 | 795 | 0.170 |
Why?
| | Firmicutes | 2 | 2021 | 18 | 0.170 |
Why?
| | Aged, 80 and over | 6 | 2021 | 7128 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Mice, Nude | 1 | 2022 | 688 | 0.170 |
Why?
| | Mouth | 1 | 2020 | 82 | 0.170 |
Why?
| | Carcinogenesis | 1 | 2022 | 210 | 0.170 |
Why?
| | Mucin 5AC | 1 | 2020 | 69 | 0.170 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 16 | 0.170 |
Why?
| | Body Mass Index | 5 | 2020 | 2268 | 0.170 |
Why?
| | Mice, Knockout | 5 | 2022 | 2811 | 0.170 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 12 | 0.170 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 113 | 0.160 |
Why?
| | Autoimmunity | 3 | 2015 | 867 | 0.160 |
Why?
| | Vascular Remodeling | 1 | 2021 | 194 | 0.160 |
Why?
| | Infant, Newborn | 5 | 2025 | 5741 | 0.160 |
Why?
| | Bacteroides | 1 | 2019 | 19 | 0.160 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.160 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 9 | 0.160 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 55 | 0.160 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 232 | 0.160 |
Why?
| | Vitamin B Complex | 1 | 2019 | 41 | 0.160 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 169 | 0.160 |
Why?
| | Oxonic Acid | 1 | 2018 | 5 | 0.150 |
Why?
| | Restraint, Physical | 1 | 2018 | 67 | 0.150 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2074 | 0.150 |
Why?
| | Organic Chemicals | 1 | 2020 | 128 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 321 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 45 | 0.150 |
Why?
| | Vitamin B 12 | 1 | 2019 | 122 | 0.150 |
Why?
| | Rats | 8 | 2023 | 5285 | 0.150 |
Why?
| | Microbiological Techniques | 2 | 2016 | 28 | 0.150 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2028 | 0.150 |
Why?
| | Corrosion | 2 | 2015 | 15 | 0.150 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 98 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 377 | 0.150 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 117 | 0.150 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 18 | 0.150 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.150 |
Why?
| | Ethanol | 1 | 2022 | 588 | 0.140 |
Why?
| | Evolution, Molecular | 2 | 2018 | 467 | 0.140 |
Why?
| | Immunoglobulin D | 1 | 2017 | 28 | 0.140 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.140 |
Why?
| | Spondylarthritis | 1 | 2018 | 45 | 0.140 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 7 | 0.140 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 166 | 0.140 |
Why?
| | Prospective Studies | 4 | 2020 | 7131 | 0.140 |
Why?
| | Alcohol Drinking | 1 | 2024 | 746 | 0.140 |
Why?
| | Lung | 4 | 2022 | 3967 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 2018 | 121 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2018 | 107 | 0.140 |
Why?
| | Birth Weight | 1 | 2020 | 499 | 0.140 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 37 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 101 | 0.140 |
Why?
| | Water Microbiology | 3 | 2016 | 85 | 0.140 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.140 |
Why?
| | Ceftriaxone | 1 | 2016 | 19 | 0.140 |
Why?
| | Down Syndrome | 1 | 2023 | 469 | 0.130 |
Why?
| | Metals | 1 | 1997 | 127 | 0.130 |
Why?
| | Metabolome | 1 | 2020 | 320 | 0.130 |
Why?
| | beta-Lactamases | 1 | 2016 | 33 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 341 | 0.130 |
Why?
| | Micronutrients | 1 | 2017 | 86 | 0.130 |
Why?
| | Autoantibodies | 3 | 2022 | 1473 | 0.130 |
Why?
| | Gene Expression | 2 | 2018 | 1487 | 0.130 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 69 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 18 | 0.130 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 54 | 0.130 |
Why?
| | Salmonella Infections | 1 | 2016 | 54 | 0.130 |
Why?
| | Vitamin E | 1 | 2016 | 118 | 0.130 |
Why?
| | Bacillus | 1 | 2015 | 16 | 0.130 |
Why?
| | Gelatin | 1 | 2016 | 41 | 0.130 |
Why?
| | Cholesterol | 3 | 2023 | 407 | 0.130 |
Why?
| | RNA, Messenger | 4 | 2018 | 2732 | 0.130 |
Why?
| | Binding Sites | 6 | 1998 | 1252 | 0.130 |
Why?
| | Symbiosis | 2 | 2017 | 70 | 0.130 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 123 | 0.130 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 7 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2017 | 730 | 0.130 |
Why?
| | Antibiosis | 1 | 2015 | 9 | 0.130 |
Why?
| | Streptococcus mitis | 1 | 2015 | 9 | 0.130 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 643 | 0.130 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 75 | 0.120 |
Why?
| | Hospitalization | 3 | 2018 | 2094 | 0.120 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.120 |
Why?
| | Metagenomics | 2 | 2019 | 153 | 0.120 |
Why?
| | Thrombophilia | 1 | 2016 | 68 | 0.120 |
Why?
| | Dietary Fats | 1 | 2017 | 303 | 0.120 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.120 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 20 | 0.120 |
Why?
| | Catalase | 1 | 2015 | 123 | 0.120 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.120 |
Why?
| | Hysterectomy | 1 | 2016 | 118 | 0.120 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 58 | 0.120 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 44 | 0.120 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 239 | 0.120 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 33 | 0.120 |
Why?
| | Thrombin | 1 | 2016 | 146 | 0.120 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 63 | 0.120 |
Why?
| | Health Facilities | 1 | 2015 | 80 | 0.120 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.120 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 177 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 170 | 0.120 |
Why?
| | Double-Blind Method | 3 | 2017 | 1878 | 0.120 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.120 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1974 | 0.120 |
Why?
| | Carrier State | 1 | 2015 | 60 | 0.120 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 84 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 147 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 218 | 0.120 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 91 | 0.120 |
Why?
| | Humidity | 1 | 2014 | 50 | 0.120 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 105 | 0.120 |
Why?
| | Household Articles | 1 | 2014 | 26 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 220 | 0.120 |
Why?
| | Gentamicins | 1 | 2015 | 52 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 105 | 0.120 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 573 | 0.120 |
Why?
| | Physical Exertion | 1 | 2015 | 215 | 0.120 |
Why?
| | Mucous Membrane | 1 | 2015 | 124 | 0.110 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 1005 | 0.110 |
Why?
| | Bifidobacterium | 3 | 2022 | 21 | 0.110 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.110 |
Why?
| | Biota | 1 | 2014 | 36 | 0.110 |
Why?
| | Maternal Welfare | 1 | 2014 | 19 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 553 | 0.110 |
Why?
| | Adiposity | 2 | 2018 | 507 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1075 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 986 | 0.110 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 42 | 0.110 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 141 | 0.110 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 29 | 0.110 |
Why?
| | Body Weight | 2 | 2015 | 938 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 962 | 0.110 |
Why?
| | Cecum | 3 | 2020 | 32 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 59 | 0.110 |
Why?
| | Preconception Care | 1 | 2014 | 39 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2014 | 85 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 733 | 0.110 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 169 | 0.110 |
Why?
| | Railroads | 1 | 2013 | 5 | 0.110 |
Why?
| | Cytokines | 4 | 2023 | 2016 | 0.110 |
Why?
| | Bacteroidetes | 3 | 2021 | 23 | 0.110 |
Why?
| | Soil Microbiology | 1 | 2015 | 207 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 63 | 0.100 |
Why?
| | Pediatric Obesity | 1 | 2020 | 573 | 0.100 |
Why?
| | Gastric Bypass | 1 | 2014 | 107 | 0.100 |
Why?
| | Antioxidants | 1 | 2016 | 562 | 0.100 |
Why?
| | Zinc Fingers | 1 | 1992 | 43 | 0.100 |
Why?
| | Burkina Faso | 1 | 2012 | 4 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 652 | 0.100 |
Why?
| | Paneth Cells | 1 | 2012 | 17 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 607 | 0.100 |
Why?
| | Xenobiotics | 1 | 2012 | 29 | 0.100 |
Why?
| | Carbon Dioxide | 1 | 2014 | 262 | 0.100 |
Why?
| | Aerosols | 1 | 2013 | 173 | 0.100 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 64 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2018 | 834 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 273 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 134 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 733 | 0.090 |
Why?
| | Genetics, Medical | 1 | 2011 | 22 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 527 | 0.090 |
Why?
| | Skin | 1 | 2016 | 742 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 159 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 546 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 773 | 0.090 |
Why?
| | Viruses | 1 | 2012 | 99 | 0.090 |
Why?
| | Lactation | 1 | 2012 | 171 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1343 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 241 | 0.090 |
Why?
| | Nutritive Value | 1 | 2010 | 36 | 0.090 |
Why?
| | Food Safety | 1 | 2010 | 18 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 383 | 0.090 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 41 | 0.090 |
Why?
| | Insulin | 2 | 2022 | 2322 | 0.090 |
Why?
| | Bacterial Capsules | 1 | 2010 | 28 | 0.090 |
Why?
| | Amphotericin B | 1 | 2010 | 29 | 0.090 |
Why?
| | Risk Factors | 4 | 2018 | 9865 | 0.080 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1372 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2018 | 10341 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1890 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 24 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 30 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 76 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 485 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 76 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 79 | 0.080 |
Why?
| | Retrospective Studies | 4 | 2022 | 14675 | 0.080 |
Why?
| | Fatty Acids | 3 | 2022 | 416 | 0.080 |
Why?
| | Prevalence | 2 | 2014 | 2576 | 0.080 |
Why?
| | Montana | 1 | 2009 | 18 | 0.080 |
Why?
| | Mississippi | 1 | 2009 | 23 | 0.080 |
Why?
| | Prostatectomy | 1 | 2009 | 105 | 0.080 |
Why?
| | Biomass | 1 | 2009 | 127 | 0.080 |
Why?
| | Sequence Alignment | 3 | 2001 | 334 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 842 | 0.080 |
Why?
| | Models, Statistical | 1 | 2013 | 630 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2017 | 1158 | 0.080 |
Why?
| | Permeability | 2 | 2022 | 158 | 0.080 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 139 | 0.080 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 92 | 0.080 |
Why?
| | Systems Integration | 1 | 2008 | 40 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 309 | 0.080 |
Why?
| | Environment | 1 | 2010 | 347 | 0.080 |
Why?
| | Housing | 1 | 2009 | 135 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2440 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 642 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2691 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 70 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 145 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 562 | 0.070 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 148 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 107 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2549 | 0.070 |
Why?
| | Prognosis | 2 | 2020 | 3830 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 41 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2013 | 728 | 0.070 |
Why?
| | Child Development | 1 | 2012 | 454 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 203 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2010 | 330 | 0.070 |
Why?
| | Plasmids | 4 | 2016 | 358 | 0.070 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 218 | 0.070 |
Why?
| | Research Personnel | 1 | 2008 | 162 | 0.070 |
Why?
| | Indomethacin | 1 | 2006 | 78 | 0.070 |
Why?
| | Peptic Ulcer | 1 | 2006 | 18 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 541 | 0.070 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 27 | 0.070 |
Why?
| | Proteobacteria | 2 | 2017 | 16 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 27 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 47 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 106 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 462 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 417 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 845 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 187 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 856 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 144 | 0.060 |
Why?
| | Artificial Intelligence | 1 | 2008 | 251 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 14 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 48 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 26 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 61 | 0.060 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1065 | 0.060 |
Why?
| | Cloning, Molecular | 3 | 1996 | 536 | 0.060 |
Why?
| | Body Composition | 2 | 2021 | 658 | 0.060 |
Why?
| | Oropharynx | 1 | 2024 | 42 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3069 | 0.060 |
Why?
| | Age Factors | 2 | 2025 | 3153 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2005 | 298 | 0.060 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 323 | 0.060 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 90 | 0.060 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 67 | 0.060 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 64 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 176 | 0.060 |
Why?
| | Comorbidity | 1 | 2009 | 1555 | 0.060 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 150 | 0.060 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 11 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 70 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 28 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 49 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 33 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1753 | 0.050 |
Why?
| | Cats | 1 | 2004 | 211 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 345 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2321 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1210 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 108 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 549 | 0.050 |
Why?
| | Pilot Projects | 2 | 2018 | 1565 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 38 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 598 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 52 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 47 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 826 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 452 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 55 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 169 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 42 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 229 | 0.050 |
Why?
| | Glycerol | 1 | 2022 | 87 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 255 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 316 | 0.050 |
Why?
| | Amniotic Fluid | 1 | 2002 | 86 | 0.050 |
Why?
| | Algorithms | 1 | 2009 | 1638 | 0.050 |
Why?
| | Smell | 1 | 2023 | 132 | 0.050 |
Why?
| | Japan | 1 | 2021 | 100 | 0.050 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 359 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 47 | 0.050 |
Why?
| | Multigene Family | 2 | 2012 | 200 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 121 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 437 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 624 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 372 | 0.050 |
Why?
| | Pigments, Biological | 1 | 2001 | 16 | 0.050 |
Why?
| | Diet, Reducing | 1 | 2021 | 84 | 0.050 |
Why?
| | RNA, Archaeal | 1 | 2001 | 16 | 0.050 |
Why?
| | Systole | 1 | 2021 | 191 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 138 | 0.050 |
Why?
| | Tight Junctions | 1 | 2021 | 75 | 0.050 |
Why?
| | Aerobiosis | 1 | 2020 | 23 | 0.050 |
Why?
| | Macrophages | 2 | 2021 | 1482 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 72 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 146 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4961 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 80 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 237 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 73 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 352 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 373 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 434 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 100 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 92 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 109 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1711 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 49 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 150 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 529 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 265 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 219 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 73 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 124 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 357 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 120 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3723 | 0.040 |
Why?
| | Lipids | 1 | 2023 | 627 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 6615 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 167 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 150 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 309 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 206 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 373 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 34 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 132 | 0.040 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 117 | 0.040 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 2 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 185 | 0.040 |
Why?
| | Collagen Type II | 1 | 2018 | 47 | 0.040 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 4 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 120 | 0.040 |
Why?
| | Acute Disease | 2 | 2016 | 981 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 491 | 0.040 |
Why?
| | Syndecan-1 | 1 | 2017 | 27 | 0.040 |
Why?
| | Magnesium | 1 | 1998 | 151 | 0.040 |
Why?
| | Powders | 1 | 2017 | 42 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2020 | 521 | 0.040 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 82 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 65 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 465 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 162 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 399 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 989 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 75 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 7 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1245 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 63 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 88 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 206 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 30 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 788 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 37 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 118 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 58 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 19 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 465 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 264 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 25 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 782 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 7 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 271 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2785 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 23 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 686 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 744 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 110 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 817 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 158 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 57 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 24 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 593 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 351 | 0.030 |
Why?
| | North America | 1 | 2016 | 290 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 47 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 85 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 351 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 58 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 29 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 18 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 520 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 599 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1020 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 159 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 2 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 88 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 415 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 5 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 25 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 469 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 46 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 76 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.030 |
Why?
| | Methane | 1 | 2014 | 49 | 0.030 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 261 | 0.030 |
Why?
| | Perioperative Care | 1 | 2015 | 150 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1983 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 32 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 63 | 0.030 |
Why?
| | Geography | 1 | 2014 | 188 | 0.030 |
Why?
| | Observer Variation | 1 | 2014 | 324 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 591 | 0.030 |
Why?
| | Models, Animal | 1 | 2015 | 373 | 0.030 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 26 | 0.030 |
Why?
| | Sequence Deletion | 1 | 1994 | 181 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 240 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 269 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 336 | 0.030 |
Why?
| | Endoscopy | 1 | 2015 | 269 | 0.030 |
Why?
| | Diarrhea | 1 | 2014 | 179 | 0.030 |
Why?
| | New York City | 1 | 2013 | 81 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 408 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 503 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 340 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 1992 | 14 | 0.030 |
Why?
| | Genes, Lethal | 1 | 1992 | 29 | 0.030 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.030 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.030 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.030 |
Why?
| | Peyer's Patches | 1 | 2012 | 8 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2786 | 0.030 |
Why?
| | Peritonitis | 1 | 2013 | 81 | 0.030 |
Why?
| | Staphylococcus | 1 | 2013 | 74 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1785 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 277 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 366 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 476 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 483 | 0.030 |
Why?
| | Cattle | 2 | 2005 | 981 | 0.030 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 182 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 328 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 730 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 292 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1510 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 44 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 388 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2639 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 88 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 578 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 373 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 376 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1239 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 766 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 585 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4930 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 121 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 484 | 0.020 |
Why?
| | Milk | 1 | 2012 | 129 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 412 | 0.020 |
Why?
| | Drug Combinations | 1 | 2012 | 328 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 106 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 428 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 641 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2100 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 229 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3310 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 868 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1201 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 606 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2735 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 379 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1107 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1291 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 456 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 7 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 822 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 283 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 22 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 37 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 15 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 194 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3380 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2060 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1714 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1433 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 405 | 0.020 |
Why?
| | RNA | 1 | 2013 | 887 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1361 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 917 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 26 | 0.020 |
Why?
| | Pediatrics | 1 | 2014 | 1063 | 0.020 |
Why?
| | Biomedical Research | 1 | 2012 | 658 | 0.020 |
Why?
| | Amino Acids | 1 | 1989 | 474 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2381 | 0.020 |
Why?
| | Guinea Pigs | 1 | 2005 | 158 | 0.020 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 13 | 0.020 |
Why?
| | Culture Media | 1 | 2005 | 168 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2016 | 2511 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 137 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 296 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 857 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 120 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2519 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 113 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 309 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 76 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 44 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1028 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1219 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1854 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 489 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 54 | 0.010 |
Why?
| | United States | 1 | 2015 | 14110 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 191 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 65 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 24 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 51 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 181 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1634 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4106 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 483 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 26 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 43 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 81 | 0.010 |
Why?
| | Genes | 1 | 1989 | 227 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 314 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1314 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|